What This Document Is
This document consists of four completed drug cards, created by a student named Vanisha Lundy for the Maternal Newborn Nursing (NUR 204) course at Jersey College Nursing School. Each card focuses on a different medication – Methotrexate, Diclegis, Toradol, and Procardia – and summarizes key information for nursing practice. The cards are formatted to include the generic and brand names, therapeutic and pharmacological classifications, indications for use, potential adverse effects, and important nursing considerations.
Why This Document Matters
This study aid is valuable for nursing students preparing for exams or clinical rotations related to maternal and newborn care. Drug cards provide a concise, readily accessible reference for frequently encountered medications. They help students quickly review essential details about each drug, promoting safe and effective medication administration. This particular set is tailored to the specific medications covered within the NUR 204 curriculum.
Common Limitations or Challenges
These drug cards represent one student’s interpretation and summarization of medication information. They should not be used as a substitute for comprehensive pharmacology textbooks, official drug references, or clinical guidance from instructors or experienced nurses. The cards offer a starting point for learning but do not encompass the full depth of knowledge required for competent nursing practice.
What This Document Provides
The full document includes completed drug cards detailing: Methotrexate (antineoplastic, antirheumatic, immunosuppressant), Diclegis (antiemetic for pregnancy-related nausea and vomiting), Toradol (NSAID for pain management and labor induction), and Procardia (antianginal/antihypertensive used for preterm labor management). This preview shows the format and types of information included on each card. It does *not* include a complete listing of all adverse effects or nursing considerations for each drug, nor does it provide detailed explanations of the underlying pharmacology.